Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2007 Aug 30:7:102.
doi: 10.1186/1471-2334-7-102.

The prevalance, epidemiology and risk factors for onychomycosis in hemodialysis patients

Güven Kuvandik  1 , Meryem Cetin, Gultekin Genctoy, Mehmet Horoz, Mehmet Duru, Cenk Akcali, Salim Satar, Ahmet A Kiykim, Hasan Kaya
Affiliations
Comparative Study

The prevalance, epidemiology and risk factors for onychomycosis in hemodialysis patients

Güven Kuvandik et al. BMC Infect Dis. .

Abstract

Background: Onychomycosis has a high prevalance among immunocompromised patients such as diabetics and hemodialysis patients. In the present study, we aimed to investigate the prevalence of onychomycosis among hemodialysis patients with and without diabetes mellitus, and to find out the factors likely to be associated with the development of onychomycosis among hemodialysis patients.

Methods: One hundred and nine hemodialysis patients were enrolled. Fifty-seven of hemodialysis patients had the diagnosis of diabetes mellitus. Nail scrapings were obtained from 76 patients who had dystrophic nail changes. Samples were examined with 20% potassium hydroxide solution and all of the samples were inoculated on Saboraud's dextrose agar, potateus dextrose agar and mycobiotic agar. Diagnosis of onychomycosis was based on the presence of both positive clinical signs and positive potassium hydroxide test.

Results: Onychomycosis was diagnosed in 26.6% of hemodialysis patients. Diabetes mellitus was present in 68.9% of patients with onychomycosis. Toenail scraping cultures were reported to be positive in 19.7% of patients with dystrophic nail changes. Logistic regression analysis revealed that the presence of diabetes mellitus and the mean duration of hemodialysis were the significant predictors associated with the development of onychomycosis.

Conclusion: The prevalence of dystrophic nail changes and onychomycosis is increased among hemodialysis patients. The dialysis duration and the presence of diabetes mellitus are the independent risk factors associated with the development of onychomycosis in uraemic patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Predicted probability of onychomycosis according to duration of dialysis in the diabetic and nondiabetic patients.
See this image and copyright information in PMC

References

    1. Sigurgeirsson B, Steingrimsson O. Risk factors associated with onychomycosis. J Eur Acad Dermatol Venereol. 2004;18:48–51. doi: 10.1111/j.1468-3083.2004.00851.x. - DOI - PubMed
    1. Sigurgeirsson B, Steingrimsson O, Sveinsdottir S. Prevalance of onychomycosis in Iceland: a poulation based study. Acta Derm Venereol. 2002;82:467–469. doi: 10.1080/000155502762064665. - DOI - PubMed
    1. Heikkila H, Stubb S. The prevalance of onychomycosis in Finland. Br J Dermatol. 1995;133:699–703. - PubMed
    1. Roberts DT. Prevalance of dermatophyte onychomycosis in United Kingdom: results of an omnibus survey. Br J Dermato. 1992;126:23–27. doi: 10.1111/j.1365-2133.1992.tb00005.x. - DOI - PubMed
    1. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Buttler B, Lowery BJ. Guidelines of care for superficial mycotic infections of the skin: onychomycosis. J Am Acad Dermatol. 1996;34:116–121. doi: 10.1016/S0190-9622(96)90843-9. - DOI - PubMed

Publication types

LinkOut - more resources